litlas
Log inCreate account

Robert A. Brodsky

Active 1997–2025

Also published as
Robert A Brodsky
113
Papers
20,590
Citations
77
h-index
111
i10-index

Citations

Citations per year for Robert A. Brodsky1998: 2 citations1999: 6 citations2000: 9 citations2001: 8 citations2002: 21 citations2003: 14 citations2004: 20 citations2005: 33 citations2006: 22 citations2007: 63 citations2008: 71 citations2009: 123 citations2010: 93 citations2011: 138 citations2012: 102 citations2013: 122 citations2014: 167 citations2015: 220 citations2016: 215 citations2017: 173 citations2018: 194 citations2019: 693 citations2020: 888 citations2021: 903 citations2022: 730 citations2023: 498 citations2024: 702 citations2025: 308 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,922 citing papers, 25.3% of this breakdownUnited Kingdom: 568 citing papers, 7.5% of this breakdownItaly: 496 citing papers, 6.5% of this breakdownGermany: 449 citing papers, 5.9% of this breakdownChina: 432 citing papers, 5.7% of this breakdownFrance: 426 citing papers, 5.6% of this breakdownSpain: 282 citing papers, 3.7% of this breakdownCanada: 262 citing papers, 3.5% of this breakdownNetherlands: 261 citing papers, 3.4% of this breakdownJapan: 230 citing papers, 3% of this breakdownSwitzerland: 177 citing papers, 2.3% of this breakdownAustralia: 168 citing papers, 2.2% of this breakdown
0%25.3%Other 25.4%

Institutions

Fields

  • Medicine58.3%
  • Immunology and Microbiology21.5%
  • Biochemistry, Genetics and Molecular Biology17.1%
  • Neuroscience0.6%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Agricultural and Biological Sciences0.4%
  • Other1.6%

Topics

  • Complement system in diseases7.6%
  • Hematopoietic Stem Cell Transplantation7.5%
  • Renal Diseases and Glomerulopathies3.2%
  • Blood groups and transfusion2.4%
  • Immune Cell Function and Interaction2.3%
  • Acute Myeloid Leukemia Research2.2%
  • Other74.8%

Coauthors

All papers

Open in search
  1. HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

    Authors: Leo Luznik, Paul V. O’Donnell, Heather J. Symons, Allen Chen, M. Susan Leffell, Marianna Zahurak, Ted Gooley, S Piantadosi, Michele Kaup, Richard F. Ambinder, Carol Ann Huff, William Matsui, Javier Bolaños‐Meade, Ivan Borrello, Jonathan D. Powell, Elizabeth B. Harrington, S. Warnock, Mary E.D. Flowers, Robert A. Brodsky, Brenda M. Sandmaier, Rainer Storb, Richard J. Jones, Ephraim J. Fuchs - Biology of Blood and Marrow Transplantation 2008 cited by 1,906

  2. Cyclophosphamide and cancer: golden anniversary

    Authors: Ashkan Emadi, Richard J. Jones, Robert A. Brodsky - Nature Reviews Clinical Oncology 2009 cited by 1,028

  3. The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

    Authors: Peter Hillmen, Neal S. Young, Jörg Schubert, Robert A. Brodsky, Gèrard Socié, Petra Muus, Alexander Röth, Jeff Szer, Modupe Elebute, Ryotaro Nakamura, Paul Browne, Antonio M. Risitano, Anita Hill, Hubert Schrezenmeier, Chieh‐Lin Fu, Jaroslaw P. Maciejewski, Scott A. Rollins, Christopher F. Mojcik, Russell P. Rother, Lucio Luzzatto - New England Journal of Medicine 2006 cited by 1,272

  4. Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

    Authors: Russell P. Rother, Scott A. Rollins, Christopher F. Mojcik, Robert A. Brodsky, Leonard Bell - Nature Biotechnology 2007 cited by 764

  5. Paroxysmal nocturnal haemoglobinuria

    Authors: Anita Hill, Amy E. DeZern, Taroh Kinoshita, Robert A. Brodsky - Nature Reviews Disease Primers 2017 cited by 439

  6. Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS

    Authors: Shruti Chaturvedi, Evan M. Braunstein, Xuan Yuan, Jia Yu, Alice Alexander, Hang Chen, Eleni Gavriilaki, Ravi Kumar Alluri, Michael B. Streiff, Michelle Petri, Mark Crowther, Keith R. McCrae, Robert A. Brodsky - Blood 2019 cited by 226

  7. Paroxysmal nocturnal hemoglobinuria

    Authors: Robert A. Brodsky - Blood 2014 cited by 630

  8. Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria

    Authors: Robert A. Brodsky, Neal S. Young, Elisabetta Antonioli, Antonio M. Risitano, Hubert Schrezenmeier, Jörg Schubert, Anna Gayà, Luke Coyle, Carlos de Castro Lozano, Chieh‐Lin Fu, Jaroslaw P. Maciejewski, Monica Bessler, Henk-André Kroon, Russell P. Rother, Peter Hillmen - Blood 2007 cited by 653

  9. Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition

    Authors: Jia Yu, Xuan Yuan, Hang Chen, Shruti Chaturvedi, Evan M. Braunstein, Robert A. Brodsky - Blood 2020 cited by 389

  10. Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications

    Authors: Shruti Chaturvedi, Evan M. Braunstein, Robert A. Brodsky - Journal of Thrombosis and Haemostasis 2020 cited by 99

  11. Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria

    Authors: Peter Hillmen, Petra Muus, Ulrich Dührsen, Antonio M. Risitano, Jörg Schubert, Lucio Luzzatto, Hubert Schrezenmeier, Jeff Szer, Robert A. Brodsky, Anita Hill, Gèrard Socié, Monica Bessler, Scott A. Rollins, Leonard Bell, Russell P. Rother, Neal S. Young - Blood 2007 cited by 578

  12. Diagnostic utility of telomere length testing in a hospital-based setting

    Authors: Jonathan K. Alder, Vidya Sagar Hanumanthu, Margaret A. Strong, Amy E. DeZern, Susan E. Stanley, Clifford M. Takemoto, Ludmila Danilova, Carolyn Applegate, Stephen G. Bolton, David W. Mohr, Robert A. Brodsky, James F. Casella, Carol W. Greider, J. Brooks Jackson, Mary Armanios - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 cited by 281

  13. Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria

    Authors: Antonio M. Risitano, Austin Kulasekararaj, Jong Wook Lee, Jaroslaw P. Maciejewski, Rosario Notaro, Robert A. Brodsky, Mingjun Huang, Michael Geffner, Peter Browett - Haematologica 2020 cited by 111

  14. Complementopathies and precision medicine

    Authors: Eleni Gavriilaki, Robert A. Brodsky - Journal of Clinical Investigation 2020 cited by 107

  15. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders

    Authors: Sarah Soden, Carol Saunders, Laurel K. Willig, Emily Farrow, Laurie D. Smith, Josh E Petrikin, Jean-Baptiste LePichon, Neil Miller, Isabelle Thiffault, Darrell L. Dinwiddie, Greyson P Twist, Aaron Noll, Bryce A. Heese, Lee Zellmer, Andrea M. Atherton, Ahmed Abdelmoity, Nicole P. Safina, Sarah S. Nyp, Britton Zuccarelli, Ingrid A. Larson, Ann Modrcin, Suzanne Herd, Mitchell Creed, Zhaohui Ye, Xuan Yuan, Robert A. Brodsky, Stephen F. Kingsmore - Science Translational Medicine 2014 cited by 532

  16. Complement in the Pathophysiology of the Antiphospholipid Syndrome

    Authors: Shruti Chaturvedi, Robert A. Brodsky, Keith R. McCrae - Frontiers in Immunology 2019 cited by 137

  17. Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria

    Authors: Robert A. Brodsky, Régis Peffault de Latour, Scott T. Rottinghaus, Alexander Röth, Antonio M. Risitano, Ilene C. Weitz, Peter Hillmen, Jaroslaw P. Maciejewski, Jeff Szer, Jong Wook Lee, Austin Kulasekararaj, Lori Volles, Andrew I. Damokosh, Stephan Ortiz, Lori Shafner, Peng Liu, Anita Hill, Hubert Schrezenmeier - Haematologica 2020 cited by 125

  18. C3 inhibition with pegcetacoplan in subjects with paroxysmal nocturnal hemoglobinuria treated with eculizumab

    Authors: Carlos de Castro, F Grossi, Ilene C. Weitz, Jaroslaw P. Maciejewski, Vivek R. Sharma, Eloy Roman, Robert A. Brodsky, Lisa Tan, Carl Di Casoli, Delphine El Mehdi, Pascal Deschatelets, Cedric Francois - American Journal of Hematology 2020 cited by 98

  19. High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease

    Authors: Leo Luznik, Javier Bolaños‐Meade, Marianna Zahurak, Allen Chen, B. Douglas Smith, Robert A. Brodsky, Carol Ann Huff, Ivan Borrello, William Matsui, Jonathan D. Powell, Yvette L. Kasamon, Steven N. Goodman, Allan D. Hess, Hyam I. Levitsky, Richard F. Ambinder, Richard J. Jones, Ephraim J. Fuchs - Blood 2010 cited by 404

  20. Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Learning Collaborative

    Authors: Josu de la Fuente, Nathalie Dhédin, Tatsuki Koyama, Françoise Bernaudin, Mathieu Kuentz, Leena Karnik, Gèrard Socié, Kathryn A. Culos, Robert A. Brodsky, Michael R. DeBaun, Adetola A. Kassim - Biology of Blood and Marrow Transplantation 2018 cited by 161

  21. Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide

    Authors: Amy E. DeZern, Marianna Zahurak, Heather J. Symons, Kenneth R. Cooke, Gary L. Rosner, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, Philip Imus, Ivan Borrello, Nina D. Wagner‐Johnston, Richard F. Ambinder, Leo Luznik, Javier Bolaños‐Meade, Ephraim J. Fuchs, Richard J. Jones, Robert A. Brodsky - Blood Advances 2020 cited by 149

  22. How I treat paroxysmal nocturnal hemoglobinuria

    Authors: Robert A. Brodsky - Blood 2009 cited by 267

  23. Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria

    Authors: Peter Hillmen, Petra Muus, Alexander Röth, Modupe Elebute, Antonio M. Risitano, Hubert Schrezenmeier, Jeff Szer, Paul Browne, Jaroslaw P. Maciejewski, Jörg Schubert, Álvaro Urbano-Ispizúa, Carlos de Castro, Gèrard Socié, Robert A. Brodsky - British Journal of Haematology 2013 cited by 387

  24. Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide

    Authors: Shannon R. McCurdy, Jennifer A. Kanakry, Margaret M. Showel, Hua-Ling Tsai, Javier Bolaños‐Meade, Gary L. Rosner, Christopher G. Kanakry, Karlo Perica, Heather J. Symons, Robert A. Brodsky, Douglas E. Gladstone, Carol Ann Huff, Keith W. Pratz, Gabrielle T. Prince, Amy E. DeZern, Ivana Gojo, William Matsui, Ivan Borrello, Michael A. McDevitt, Lode J. Swinnen, B. Douglas Smith, Mark J. Levis, Richard F. Ambinder, Leo Luznik, Richard J. Jones, Ephraim J. Fuchs, Yvette L. Kasamon - Blood 2015 cited by 300